MTNB · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2023-08-09 compared with 2023-05-10 · 5 added, 2 removed, 28 unchanged (20% of the section changed)
4 unchanged sentences
the undersigned thereunto duly authorized.
−Removed: BIOPHARMA HOLDINGS, INC.
+Added: MATINAS BIOPHARMA HOLDINGS, INC.
+Added: August 9, 2023
Executive Officer (Principal Executive Officer)
+Added: August 9, 2023
Financial Officer
7 unchanged sentences
Description of Securities (incorporated herein by reference to the Company’s Annual Report on Form 10-K filed with the SEC on March 8, 2022).
−Removed: Certification of Chief Executive Officer
+Added: Certification
+Added: of Chief Executive Officer
Certification of Chief Financial Officer
12 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.